Aclidinium bromide/formoterol fumarate dihydrate


( Last Updated : February 24, 2015)
Generic Name:
Aclidinium bromide/formoterol fumarate dihydrate
Project Status:
Complete
Therapeutic Area:
Chronic obstructive pulmonary disease
Manufacturer:
AstraZeneca Canada Inc.
Call for patient/clinician input open:
Brand Name:
Duaklir Genuair
Project Line:
Reimbursement Review
Project Number:
SR0423-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
Chronic Obstructive Pulmonary Disease (COPD)
Recommendation Type:
List with clinical criteria and/or conditions
Final Recommendation: